News
-
-
PRESS RELEASE
Curiteva Announces the Beginning of the Commercial Launch of the Inspire(R) Posterior Interbody Solutions
Curiteva, Inc. launches FDA-cleared Inspire Posterior Interbody Fusion Solutions with 3D Printed Trabecular PEEK. Experts praise bone ingrowth potential. Company uses VESTAKEEP i4 3DF PEEK polymer. Inspire Technology showcased at event -
-
PRESS RELEASE
Curiteva Surpasses 1,000 Procedures With Inspire(R) Cervical Trabecular PEEK(TM) With HAFUSE(R) Technology
Curiteva, Inc. announces milestone of over 1,000 patients treated with 3D printed Inspire Cervical Trabecular PEEK Interbody Fusion System, with superior biomechanics and bone formation. Company plans to expand technology into lumbar region -
-
-
-
-
PRESS RELEASE
Renowned Neurosurgeon Dr. Kevin Foley Appointed to Curiteva’s Board of Directors
Curiteva appoints Dr. Kevin Foley, MD, a distinguished neurosurgeon and inventor, to its board of directors. Dr. Foley will bring significant clinical insights to the company's cutting-edge technology and groundbreaking Inspire 3D Printed Trabecular PEEK implant -
PRESS RELEASE
Inspire(R) 3D Printed Trabecular PEEK(TM) With HAFUSE(R) Lumbar Interbody System Cleared by FDA
Curiteva, a technology manufacturer based in Huntsville, AL, has announced FDA 510(k) clearance for their Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System, marking their second FDA cleared 3D printed PEEK implant. The proprietary printing operation and rigorous quality and process controls demonstrate the company's commitment to operational efficiency. The groundbreaking additive process produces a fully interconnected trabecular PEEK lattice structure to promote osseointegration and superior biomechanics. The company's commitment to lean operational efficiency has resulted in over 7,000 implants now commercially available in inventory. Curiteva plans to publish patient outcomes for Inspire cervical implant later this year, reinforcing their pre-clinical observations. For more information, visit www.curiteva.com.